A nutritional supplement based on bovine serum will be used, which is very rich in immunoglobulins, vitally important antibodies that circulate in the bloodstream and, in this case, act on one of the ...
Read more
With the participation of the Breast Unit of the Arnau de Vilanova University Hospital and IRBLleida
Read more
The results confirm a clinically and statistically significant improvement in trough FEV1 of asthmatic patients taking 10mg of PBF-680 for 14 days compared to placebo.
Read more
Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, has presented t...
Read more
The biotech company Oxolife, created to develop a new treatment to improve the female fertility rate, completed its first funding round by raising 5,000,000 euros in an investment led by Inveready Ass...
Read more
The clinical trial, which plans to include a total of up to 300 patients, has recently begun to include the first patients in Madrid and will incorporate up to 25 European center.
Read more
The General Directorate of Research and Innovation in Health of the Government of Catalonia will finance a clinical trial to study the protective effect of Ruti®, developed by Archivel Farma, on SARS...
Read more
Versantis, a pharmaceutical company focused on the development of products addressing a high unmet medical need in the diagnosis, prevention, and treatment of liver diseases, today announces the closi...
Read more
Oryzon Genomics, S.A.(ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced...
Read more
The Oncogenesis and Antitumor Research Group, from the Research Institute of the Hospital de Sant Pau-IIB Sant Pau, led by Dr. Ramon Mangues, has developed the first nanometric-sized drug that is sele...
Read more
AbilityPharma (Ability Pharmaceuticals, SL) a biopharmaceutical company developing oncology drugs, announced today that the company will release the first results of the currently ongoing phase 1/2...
Read more
Published this month in the International Journal of Radiation Oncology, Biology, Physics*, findings first authored by Joan Carles, Principal Investigator of VHIO’s Genitourinary, CNS Tumors, Sar...
Read more
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
Un equipo de investigadores de la Universidad Juli...
En nuestro post hablamos sobre este interesante tipo de célula del...
Regenera Activa Worldwide and Rigenera HBW, biotech firms specializing...
